Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
PIONEER — Prospective Natural History Study of POLG DiseaseThe PIONEER study is a prospective, natural history study dedicated to characterizing the clinical progression of POLG-related disorders. The research aims to bridge the gap between genetic diagnosis and drug development by mapping how these rare mitochondrial conditions evolve over time. By observing the disease's natural trajectory through a multi-center approach, The study identifies critical clinical milestones that serve as a foundation for evaluating therapeutic efficacy and future therapeutic interventions Épilepsie À vérifier Remyélinisation indirecte / réparation + Ralentissement de la progression United States À vérifier
PIONEER — Prospective Natural History Study of POLG DiseaseThe PIONEER study is a prospective, natural history study dedicated to characterizing the clinical progression of POLG-related disorders. The research aims to bridge the gap between genetic diagnosis and drug development by mapping how these rare mitochondrial conditions evolve over time. By observing the disease's natural trajectory through a multi-center approach, The study identifies critical clinical milestones that serve as a foundation for evaluating therapeutic efficacy and future therapeutic interventions Épilepsie À vérifier Remyélinisation indirecte / réparation + Ralentissement de la progression United States À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
PIONEER — Prospective Natural History Study of POLG Disease Épilepsie À vérifier NCT07775872 PIONEER — Prospective Natural History Study of POLG Disease NOT_YET_RECRUITING

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.